Trending:
Aurobindo Pharma gets U.S. FTC go-ahead to acquire Lannett Company

The U.S. Federal Trade Commission (FTC) has approved Aurobindo Pharma’s proposed acquisition of Pennsylvania-based generic pharmaceutical firm Lannett Company.Valued at $250 million on a cash-free, debt-free basis and inclusive of normalised working capital, the transaction is expected to close be...

Matin Libre
Matin Libre

matinlibre.com




See also: